For example, epidermal growth factor receptor (EGFR) targeting has been used to treat advanced colon cancer [6, 7], and an anti-interleukin-6 (IL-6) receptor antibody has been used to suppress angiogenesis and inhibit CRC growth [8]. Here, EGFR is linked to malignant colon neoplasm.